Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 965

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 965
---
 of deposits or other payments received by the Company but not yet credited to the bank accounts of the Company, and (ii) Cash shall be reduced by the amount
of any outstanding checks or other payments issued by the Company but not yet deducted from the bank accounts of the Company;

(f)
“” means a dollar amount equal to (i) Fifteen Million Dollars ($15,000,000), (ii) Five Million Dollars ($5,000,000) relating to Parent’s exclusivity payment under the
Exclusivity Agreement, (iii) Three Hundred Thousand Dollars ($300,000) relating to Parent’s extension payment under the Exclusivity Agreement, (iv) $695,000, (v) the Loaned Amount, if any,
(vi) the Estimated Net Working Capital Surplus, if any, (vii) the Estimated Net Working Capital Deficit, if any;

(g) “” means the aggregate amount of all Cash and Cash Equivalents of the Company as of
12:01 A.M. Eastern Time on the Closing Date;

(h) “” means the aggregate amount of all
Liabilities and Debt of the Company as of 12:01 A.M. Eastern Time on the Closing Date;

(i) “” means the Net Working Capital Amount of the Company as of 12:01 A.M. Eastern Time on the Closing Date;

(j)
“” means the Internal Revenue Code of 1986, as amended.

(k) “” means the representations and warranties of the Company set forth in ;

A-54

(l) “” means any and all information controlled or Processed by
or on behalf of the Company or any of its Subsidiaries, including, without limitation, Personal Data as well as confidential and proprietary data of the Company and/or its Subsidiaries;

(m) “” means the number of shares of Parent Common Stock equal to the quotient of
(i) the difference of (A) Five Million Dollars ($5,000,000), (B) the Holdback Liabilities Amount, if any, (C) Delayed Net Working Capital Amount, if any, (ii) the Parent Share
Value, rounded down to the nearest whole share; , , in no event shall the Company Delayed Share Consideration be less than zero;

(n) “” shall equal (i) the aggregate number of shares of Company Common Stock issued
and outstanding immediately prior to the Effective Time (ii) the aggregate number of shares of Company Common Stock issuable upon